Key points are not available for this paper at this time.
SIGNIFICANCE: Reducing the incidence or prevalence of any disease by 40% is of huge public health significance. Slowing myopia by 1 diopter may do just that for myopic maculopathy-the most common and serious sight-threatening complication of myopia. There is a growing interest in slowing the progression of myopia due to its increasing prevalence around the world, the sight-threatening consequences of higher levels of myopia, and the growing evidence-based literature supporting a variety of therapies for its control. We apply data from five large population-based studies of the prevalence of myopic maculopathy on 21,000 patients. We show that a 1-diopter increase in myopia is associated with a 67% increase in the prevalence of myopic maculopathy. Restated, slowing myopia by 1 diopter should reduce the likelihood of a patient developing myopic maculopathy by 40%. Furthermore, this treatment benefit accrues regardless of the level of myopia. Thus, while the overall risk of myopic maculopathy is higher in a -6-diopter myope than in a -3-diopter myope, slowing their myopic progression by 1 diopter during childhood should lower the risk by 40% in both.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mark A. Bullimore
Noel A. Brennan
Optometry and Vision Science
University of Houston
University of Colorado System
Johnson & Johnson (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Bullimore et al. (Tue,) studied this question.
www.synapsesocial.com/papers/6a008d57831589f3542ddaea — DOI: https://doi.org/10.1097/opx.0000000000001367
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: